Thu, May 15, 8:26 PM (38 days ago)
**Cardio Diagnostics Holdings, Inc. (CDIO) Q1 2025 Financial Summary** **Financial Health & Performance:** - **Revenue:** $940,000 (Q1 2024: $15,928,000) - **Net Loss:** $1,635,064 (Q1 2024: $4,163,584) - **Cash Position:** $9,688,719 (Q1 2024: $7,827,487) - **Operating Expenses:** $1,631,500 (Q1 2024: $4,173,976) - **General & Administrative Expenses:** $1,542,042 (Q1 2024: $4,123,941) - **Sales & Marketing:** $41,820 (Q1 2024: $34,402) - **Research & Development:** $2,200 (Q1 2024: $10,840) - **Amortization:** $45,438 (Q1 2024: $4,793) **Profit Margins & Cash Flow:** - **Gross Margin:** Not explicitly stated. - **Operating Margin:** Negative due to operating loss. - **Net Margin:** Negative due to net loss. - **Cash Flow from Operations:** Negative $1,400,101 (Q1 2024: Negative $1,233,050) - **Cash Flow from Investing:** Negative $47,415 (Q1 2024: Negative $69,941) - **Cash Flow from Financing:** Positive $3,308,748 (Q1 2024: Positive $1,582,607) **Earnings Changes & Quarterly Performance:** - **Earnings per Share (EPS):** Negative $0.97 (Q1 2024: Negative $5.93) - **Weighted Average Shares Outstanding:** 1,686,144 (Q1 2024: 702,574) **Trends & Uncertainties:** - **Revenue Decline:** Significant drop in revenue, indicating challenges in sales or market penetration. - **Expense Reduction:** Notable decrease in general and administrative expenses, primarily due to reduced stock compensation. - **Cash Position:** Improved cash position, largely due to financing activities. - **Operational Challenges:** Long sales and partnership cycles, regulatory uncertainties, and potential legal claims. **Future Operations & Impact:** - **Strategic Initiatives:** Focus on developing additional products, expanding clinical evidence, leveraging new CPT codes, and pursuing strategic partnerships. - **Regulatory Uncertainties:** Ongoing legal and regulatory challenges, including potential FDA regulations on LDTs. - **Financial Needs:** Continued need for external financing to support operations and growth. **Key Takeaways:** - **Financial Struggles:** Significant net loss and revenue decline indicate ongoing financial challenges. - **Operational Focus:** Efforts to expand product offerings and partnerships, despite long sales cycles. - **Regulatory & Legal Risks:** Potential impacts from regulatory changes and legal claims. - **Cash Management:** Improved cash position but continued reliance on external financing.